<< return to program

Richard Harland

Novartis Animal Health Canada, Inc.
Calgary, AB, Canada

Vaccines for Companion Animals and Livestock

Tuesday, September 14, 2010
2:00 - 2:30 pm

Abstract:  This presentation is an overview of Animal Health vaccines and of new technologies being adopted for vaccines to improve efficacy and safety.  Some of the new technologies discussed include recombinant sub-unit vaccines, nucleic acid vaccines, viral vectors, recombinant subunits, antigen discovery, delivery methods and adjuvants.

Biography

• Graduated as a veterinarian from Western College of Veterinary Medicine, University of Saskatchewan in 1982.
• Practiced in Humboldt, Saskatchewan and focused on cattle and equine practice from 1982 to 1985.
• Returned to WCVM in 1985 and completed a Residency in Herd Medicine and a Masters of Veterinary Science (Epidemiology)in 1987.
• In 1988 held split position at WCVM Ambulatory clinician with students on farm calls and Veterinary Infectious Disease Organization for clinical research.
• From 1989 to 1992 as a Research Scientist at V.I.D.O. developing vaccines
• From 1992 to 1995 as a Manager of Clinical Research at VIDO
• Moved to Biostar a Biotech company in 1996 as the Manger of Clinical Affairs and Technical Services primary focus on vaccine research.
• In 2000 Biostar was purchased by Novartis Animal Health, I became Director of R & D (Vaccines) for North America.
• Since 2006 Head Global Vaccines Lead Finding, acquiring new vaccine technology for Novartis Animal Health and especially working closely with our human vaccine company Novartis Vaccines and Diagnostics to build collaborations and sharing vaccine technologies between the human and animal health divisions.